News

```htmlGolden Ten Data reported on May 6 that Eli Lilly (LLY.N) has initiated an investment-grade bond issuance to raise funds for its recent series of acquisition deals. According to sources familiar with the matter, Eli Lilly plans to issue bonds with up to eight maturities, ranging from 2 years to 40 years. The longest bond, maturing in 2066, has a preliminary price guidance of approximately 113 basis points above U.S. Treasury yields. Eli Lilly is currently undertaking large-scale acquisitions. In the past two months, the company completed acquisitions of Centessa Pharmaceuticals Plc, a sleep medication developer, for up to $7.8 billion, and Kelonia Therapeutics, a cancer drug developer, for up to $7 billion. Both deals rank among the most expensive acquisitions in Eli Lilly’s history. CEO Dave Ricks stated that investors should expect more deals in the future. The bond issuance also coincides with Eli Lilly’s strong first-quarter performance, as the company raised its full-year sales and profit forecasts.```

Glonghui, May 6th｜Kraft Heinz announced that its first-quarter sales reached $6.05 billion, surpassing analysts’ expectations of $5.89 billion, driven by strategic initiatives from new CEO Steve Cahillane and improved U.S. business demand. Adjusted earnings per share stood at 58 cents, higher than analysts’ forecasts of 50 cents. The company expects adjusted earnings per share for the full year to be in the range of $1.98 to $2.10, while the market expects $2.04.

BlockBeats News, May 6th, according to an exchange market data, TON has surpassed $2.3, currently trading at $2.367, with a 24-hour price increase of 24.9%. On May 4th, Telegram founder Pavel Durov announced on his personal channel that Telegram will replace the TON Foundation as the driving force behind TON and become its largest validator. TON has surged from $1.375 on May 4th to today's $2.367, representing a total increase of about 72.15%.